137 related articles for article (PubMed ID: 33044742)
81. Nodular lymphocyte-predominant hodgkin lymphoma.
Tsai HK; Mauch PM
Semin Radiat Oncol; 2007 Jul; 17(3):184-9. PubMed ID: 17591565
[TBL] [Abstract][Full Text] [Related]
82. Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).
Schulz H; Rehwald U; Morschhauser F; Elter T; Driessen C; Rüdiger T; Borchmann P; Schnell R; Diehl V; Engert A; Reiser M
Blood; 2008 Jan; 111(1):109-11. PubMed ID: 17938252
[TBL] [Abstract][Full Text] [Related]
83. Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options.
Shankar A; Daw S
Br J Haematol; 2012 Nov; 159(3):288-98. PubMed ID: 22994199
[TBL] [Abstract][Full Text] [Related]
84. Moraxella catarrhalis induces an immune response in the murine lung that is independent of human CEACAM5 expression and long-term smoke exposure.
Gutbier B; Fischer K; Doehn JM; von Lachner C; Herr C; Klaile E; Frischmann U; Singer BB; Riesbeck K; Zimmermann W; Suttorp N; Bachmann S; Bals R; Witzenrath M; Slevogt H
Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(3):L250-61. PubMed ID: 26047639
[TBL] [Abstract][Full Text] [Related]
85. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
86. Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients.
Amedei A; Della Bella C; Niccolai E; Stanflin N; Benagiano M; Duranti R; Del Prete G; Murphy TF; D'Elios MM
Int J Immunopathol Pharmacol; 2009; 22(4):979-90. PubMed ID: 20074461
[TBL] [Abstract][Full Text] [Related]
87. Refractory nodular lymphocyte predominant Hodgkin lymphoma transformed to T-cell/histiocyte-rich B-cell lymphoma in an adolescent: salvage therapy with allogeneic bone marrow transplantation.
Couronné L; Schneider P; Picquenot JM; Laberge S; Bastard C; Vannier JP
J Pediatr Hematol Oncol; 2008 Dec; 30(12):959-62. PubMed ID: 19131792
[TBL] [Abstract][Full Text] [Related]
88. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
89. Multiple Cavitary Lung Lesions in an Adolescent: Case Report of a Rare Presentation of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Soliman M; Neemuchwala F; Sankar A; Jasty R; Rabah R; Popova AP; Newman EA
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e454-e457. PubMed ID: 30102646
[TBL] [Abstract][Full Text] [Related]
90. B-cell receptor reactivity against
Thurner L; Fadle N; Regitz E; Roth S; Cetin O; Kos IA; Hess SM; Bein J; Bohle RM; Vornanen M; Sundström C; De Leval L; Tiacci E; Borchmann P; Engert A; Poeschel V; Held G; Schwarz EC; Neumann F; Preuss KD; Hoth M; Küppers R; Lehman K; Hansmann ML; Becker SL; Bewarder M; Hartmann S
Haematologica; 2023 Dec; 108(12):3347-3358. PubMed ID: 37139600
[TBL] [Abstract][Full Text] [Related]
91. Clonality and germinal centre B-cell derivation of Hodgkin/Reed-Sternberg cells in Hodgkin's disease.
Küppers R; Hansmann ML; Rajewsky K
Ann Oncol; 1998; 9 Suppl 5():S17-20. PubMed ID: 9926232
[TBL] [Abstract][Full Text] [Related]
92. Progressive transformation of germinal centers: review of histopathologic and clinical features.
Hicks J; Flaitz C
Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(3):195-202. PubMed ID: 12242134
[TBL] [Abstract][Full Text] [Related]
93. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
Carbone A; Gloghini A
Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
[TBL] [Abstract][Full Text] [Related]
94. Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria.
Ballas LK; Metzger ML; Milgrom SA; Advani R; Bakst RL; Dabaja BS; Flowers CR; Ha CS; Hoppe BS; Mansur DB; Pinnix CC; Plastaras JP; Roberts KB; Smith SM; Terezakis SA; Constine LS
Leuk Lymphoma; 2021 May; 62(5):1057-1065. PubMed ID: 33274673
[TBL] [Abstract][Full Text] [Related]
95. A role for TLRs in Moraxella-superantigen induced polyclonal B cell activation.
Singh K; Bayrak B; Riesbeck K
Front Biosci (Schol Ed); 2012 Jan; 4(3):1031-43. PubMed ID: 22202107
[TBL] [Abstract][Full Text] [Related]
96. Molecular biology of Hodgkin lymphoma.
Weniger MA; Küppers R
Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
[TBL] [Abstract][Full Text] [Related]
97. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Panayi C; Akarca AU; Ramsay AD; Shankar AG; Falini B; Piris MA; Linch D; Marafioti T
Front Oncol; 2023; 13():1267604. PubMed ID: 37854674
[TBL] [Abstract][Full Text] [Related]
98. Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma.
Straus DJ
Haematologica; 2021 Oct; 106(10):2538. PubMed ID: 33882643
[No Abstract] [Full Text] [Related]
99. Lymphocyte predominant Hodgkin lymphoma, antigen-driven after all?
Poppema S
J Pathol; 2021 Jan; 253(1):1-10. PubMed ID: 33044742
[TBL] [Abstract][Full Text] [Related]
100. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma.
Thurner L; Hartmann S; Fadle N; Regitz E; Kemele M; Kim YJ; Bohle RM; Nimmesgern A; von Müller L; Kempf VAJ; Weniger MA; Neumann F; Schneider N; Vornanen M; Sundström C; de Leval L; Engert A; Eichenauer DA; Küppers R; Preuss KD; Hansmann ML; Pfreundschuh M
Nat Commun; 2020 May; 11(1):2465. PubMed ID: 32424289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
